Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03505541 · ClinicalTrials.gov registry record
Adipokines Effect in Myometrial Contractility
A clinical trial of Obesity and GDM, sponsored by University of Minnesota.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT03505541 is a study of Obesity and GDM that has completed, run by University of Minnesota. The registered enrollment target is 60 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03505541, a study of Obesity and GDM, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigate the effect of two adipokines which are adiponectin and TNFa on the force of myometrial contractility in diabetic, non-obese pregnant women and obese, non-diabetic term pregnant women at the time of scheduled cesarean delivery
Conditions Studied
Interventions
- BIOLOGICAL Adiponectin and TNFa
Study Locations (1)
Minnesota
- Fairview Hospital - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2019-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03505541
The ClinicalTrials.gov registry entry for NCT03505541 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Adiponectin and TNFa is the first listed.
NCT03505541 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03505541 about?
NCT03505541 is a clinical study titled "Adipokines Effect in Myometrial Contractility". Investigate the effect of two adipokines which are adiponectin and TNFa on the force of myometrial contractility in diabetic, non-obese pregnant women and obese, non-diabetic term pregnant women at the time of scheduled cesarean delivery
What is the current status of trial NCT03505541?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-08-01. Estimated completion is 2019-07-01.
What conditions does trial NCT03505541 study?
This clinical trial studies the following conditions: Obesity, GDM, Myometrium; Contractility.
What interventions are being tested in trial NCT03505541?
The interventions under investigation include: Adiponectin and TNFa (BIOLOGICAL).
Who is sponsoring clinical trial NCT03505541?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03505541 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.